Vericiguat: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Vericiguat. Educational only — not medical advice.
Labeled uses
VERQUVO® is indicated to reduce the risk of cardiovascular death and heart failure (HF) hospitalization following a hospitalization for heart failure or need for outpatient IV diuretics, in adults with symptomatic chronic HF and ejection fraction less than 45% [see Clinical Studies (14) ] .
Source: FDA labeling via NIH DailyMed (set 17056d73…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.